RUNX3 is involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukaemia cell lines. [electronic resource]
Producer: 20120416Description: 439-49 p. digitalISSN:- 1432-1335
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Azacitidine -- administration & dosage
- Blotting, Western
- Caspase 3 -- metabolism
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Core Binding Factor Alpha 3 Subunit -- metabolism
- CpG Islands
- Fluorescent Antibody Technique
- Gene Expression Regulation, Neoplastic
- Humans
- Hydroxamic Acids -- administration & dosage
- K562 Cells
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Reverse Transcriptase Polymerase Chain Reaction
- Up-Regulation
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.